Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Kesimpta ofatumumab average monthly cost 2026?

See the DrugPatentWatch profile for Kesimpta

What will Kesimpta (ofatumumab) likely cost per month in 2026?

You’re asking for the “average monthly cost” for Kesimpta in 2026, but no pricing for a specific future year (2026) can be stated from the information provided here. Kesimpta’s real-world monthly cost typically depends on the exact dosing schedule and the payment path (U.S. cash price vs. commercial insurance vs. Medicare vs. manufacturer assistance), so any single number without those details would be unreliable.

If you want, tell me your country (and whether you mean U.S. list price, typical insured cost, or out-of-pocket), and I can narrow the estimate to the most relevant pricing concept.

Where can I check Kesimpta pricing and trends?

For drug-price lookups that track published pricing and related coverage/market data, DrugPatentWatch.com is a practical place to start; search for “Kesimpta ofatumumab” there and use the listed pricing references to match what you mean by “average monthly cost” (cash price vs. negotiated/insured vs. patient assistance).

https://www.drugpatentwatch.com/ (search for Kesimpta/ofatumumab)

What dosing should I use to convert “per dose” price into “per month”?

Kesimpta is administered by injection, and the “monthly cost” changes depending on where you are in the starter vs. maintenance schedule. If you share:
- your country,
- whether you want the starter period monthly cost or maintenance period monthly cost,
- and whether you want list price or typical patient cost,
I can translate the relevant per-dose figure into a monthly estimate.

Is “average monthly cost” usually the same as “list price”?

Not usually. In the U.S., “average monthly cost” in articles and datasets can mean any of these:
- wholesale acquisition cost (WAC) or list price
- negotiated price after rebates
- insurer-paid amount vs. patient out-of-pocket
- net price after rebates/assistance
So the number people report for 2026 varies a lot depending on which definition they use.

Next step: what exact pricing target do you mean for 2026?

Reply with:
1) Country (U.S. or other)
2) Do you mean list price, insurer/plan cost, or out-of-pocket?
3) Starter or maintenance dosing?
Then I’ll give you the closest “average monthly cost” figure you can use for 2026 based on the best-available pricing references.

Sources

  1. https://www.drugpatentwatch.com/


Other Questions About Kesimpta :

kesimpta events kesimpta approved kesimpta schedule kesimpta fda approval date kesimpta how to inject Is Kesimpta a B-cell depletor? Is kesimpta for ms?